InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,652.00
(
0.06%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,717.33
(
-0.13%
)
Post# of 23689
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mick

Send PM Follow Ignore
Followers 3157
Posts 961338
Boards Moderated 204
Alias Born 09/04/2000

mick

Member Level

Re: None

Monday, 12/01/2014 10:32:31 PM

Monday, December 01, 2014 10:32:31 PM

Post# of 23689
FDA Accepts IDE Supplement for INTERCEPT Blood System Treatment of Ebola Convalescent Plasma
Business Wire via Yahoo! Finance Nov 21 05:30am
Cerus Corporation today announced that the U.S. Food and Drug Administration has accepted Cerus’ clinical protocol to make the INTERCEPT Blood System for plasma available under an Investigational Device Exemption for treatment of convalescent plasma collected from Ebola disease survivors for passive immune therapy.

https://finance.search.yahoo.com/search;_ylt=AwrSyCVsamJUZD0AapGTmYlQ?p=any+new+ebola+outbreaks&fr2=sb-top&fr=uh3_finance_vert_gs&type=2button
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up